RA Capital Management reports $1.43 million purchase of Artiva Biotherapeutics shares - ARTV News | RalliesRA Capital Management reports $1.43 million purchase of Artiva Biotherapeutics shares
A
ARTV• RA Capital Management reports additional Artiva Biotherapeutics purchases
- RA Capital Management reported additional purchases of Artiva Biotherapeutics common stock.
- Total beneficial ownership rose to 16,977,927 shares, held indirectly.
- Purchases covered 160,354 shares at weighted average prices of $8.93, $8.95.
•
